Evidence map›Paper›PMID 25595793›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Evasion of innate cytosolic DNA sensing by a gammaherpesvirus facilitates establishment of latent infection.

Chenglong Sun, Stefan A Schattgen, Prapaporn Pisitkun, Joan P Jorgensen, Adam T Hilterbrand, Lucas J Wang, John A West, Kathrine Hansen, Kristy A Horan, Martin R Jakobsen and 8 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 91 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Chenglong SunDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark;
Stefan A SchattgenDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655;
Prapaporn PisitkunDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark; Department of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand 10400;
Joan P JorgensenDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark;
Adam T HilterbrandDepartment of Molecular Biosciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712;
Lucas J WangDepartment of Molecular Biosciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712;
John A WestDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599;
Kathrine HansenDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark;
Kristy A HoranDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark;
Martin R JakobsenDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark;
Peter O'HareSection of Virology, Faculty of Medicine, Imperial College, St. Mary's Campus, London W2 1PG, United Kingdom;
Heiko AdlerHelmholtz Zentrum Munich, German Research Center for Environmental Health, D-81377 Munich, Germany;
Ren SunDepartment of Molecular Biology and Medical Pharmacology, Faculty of Medicine, University of California, Los Angeles, Los Angeles, CA 90095; and.
Hidde L PloeghWhitehead Institute for Biomedical Research, Cambridge, MA 02142.
Blossom DamaniaDepartment of Microbiology and Immunology, University of North Carolina, Chapel Hill, Chapel Hill, NC 27599;
Jason W UptonDepartment of Molecular Biosciences, Institute for Cellular and Molecular Biology, University of Texas at Austin, Austin, TX 78712;
Katherine A FitzgeraldDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, MA 01655;
Søren R PaludanDepartment of Biomedicine, Aarhus University, DK-8000 Aarhus C, Denmark; Aarhus Research Center for Innate Immunology, Aarhus University, DK-8000 Aarhus C, Denmark; srp@biomed.au.dk.
Aarhus University · DKThe University of Texas at Austin · USAarhus University Hospital · DKUniversity of Massachusetts Chan Medical School · USUniversity of North Carolina at Chapel Hill · USCenter for Environmental Health · USImperial College London · GBUniversity of California, Los Angeles · USWhitehead Institute for Biomedical Research · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Vironomics and Biostatistics CoreP01CA019014 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BLOSSOM A DAMANIA, NANCY JOAN RAAB-TRAUB · 1985 to 2026
$43.8M
Proteomics Pathway DiscoveryU19AI109965 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUNCAN, JOSEPH A · 2014 to 2018
$14.9M
Study of Novel HHV8/KSHV Encoded GenesU19AI107810 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DITTMER, DIRK P · 2013 to 2017
$10.6M
TRAINING IN IMMUNOLOGY (COMPETITIVE RENEWAL OF AI07439)T32AI007349 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI STERN, LAWRENCE J. · 1989 to 2024
$4.5M
Reactivation of Kaposi's Sarcoma-Associated HerpesvirusR01CA091791 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SUN, REN · 2001 to 2017
$4.4M
Innate Immunity and KSHVR01DE018281 · NIDCR · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAMANIA, BLOSSOM A · 2007 to 2016
$3.5M
Innate Immunity Training ProgramT32AI095213 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SILVERMAN, NEAL · 2011 to 2025
$2.5M
Role of PISA; a PYHIN Family Member in Intracellular DNA RecognitionR01AI083713 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A., LATZ, EICKE · 2009 to 2013
$2.0M
DNA sensors and associated signaling pathways in the innate immune responseR01AI093752 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI FITZGERALD, KATHERINE A. · 2012 to 2016
$1.7M
NCI NIH HHS CA019014NCI NIH HHS P01 CA019014NCI NIH HHS P30 CA016042NCI NIH HHS R01 CA091791NIAID NIH HHS AI083713NIAID NIH HHS AI093752NIAID NIH HHS AI107810NIAID NIH HHS AI109965NIAID NIH HHS R01 AI083713NIAID NIH HHS R01 AI093752NIAID NIH HHS T32 AI007349NIAID NIH HHS T32 AI095213NIAID NIH HHS U19 AI107810NIAID NIH HHS U19 AI109965NIDCR NIH HHS DE018281NIDCR NIH HHS R01 DE018281
6 · The paper itself

Abstract

Herpesviruses are DNA viruses harboring the capacity to establish lifelong latent-recurrent infections. There is limited knowledge about viruses targeting the innate DNA-sensing pathway, as well as how the innate system impacts on the latent reservoir of herpesvirus infections. In this article, we report that murine gammaherpesvirus 68 (MHV68), in contrast to α- and β-herpesviruses, induces very limited innate immune responses through DNA-stimulated pathways, which correspondingly played only a minor role in the control of MHV68 infections in vivo. Similarly, Kaposi's sarcoma-associated herpesvirus also did not stimulate immune signaling through the DNA-sensing pathways. Interestingly, an MHV68 mutant lacking deubiquitinase (DUB) activity, embedded within the large tegument protein open reading frame (ORF)64, gained the capacity to stimulate the DNA-activated stimulator of IFN genes (STING) pathway. We found that ORF64 targeted a step in the DNA-activated pathways upstream of the bifurcation into the STING and absent in melanoma 2 pathways, and lack of the ORF64 DUB was associated with impaired delivery of viral DNA to the nucleus, which, instead, localized to the cytoplasm. Correspondingly, the ORF64 DUB active site mutant virus exhibited impaired ability to establish latent infection in wild-type, but not STING-deficient, mice. Thus, gammaherpesviruses evade immune activation by the cytosolic DNA-sensing pathway, which, in the MHV68 model, facilitates establishment of infections.

Indexed as

AnimalsCytosolDisease Models, AnimalDNA, ViralEnzyme-Linked Immunosorbent AssayFlow CytometryGammaherpesvirinaeHerpesviridae InfectionsHumansImmunity, InnateMacrophagesMiceMice, Inbred C57BLMice, KnockoutMicroscopy, ConfocalReal-Time Polymerase Chain ReactionDNA, Viral

Identifiers

PMID25595793
PMCPMC4323864
OpenAlexW1629500030

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.